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1. Introduction 
In the course of a search for inhibitors of RNA 
polymerase (EC 2.7.7.6) from E. coli, it was found 
that several sulphydryl reagents were able to inactivate 
the enzyme. Since N-ethylmaleimide was among the 
compounds found to be inhibitory, it was decided to 
examine the effectiveness of the naturally occurring 
maleimide antibiotic, showdomycin. This is an anti- 
biotic produced by Streptomyces showdoensis which 
inhibits the growth of several bacteria [I] . It has the 
structure 3+-D-ribofuranosylmaleimide [2] (fig. 1). 
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Fig. 1. Showdomycin. 
The results indicate that showdomycin is an effec- 
tive inhibitor, and that DNA, and to a lesser extent 
the metals used in the assay, Mg*” and Mn*+, are able 
to protect the enzyme against inactivation. 
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2. Materials and methods 
2.1. Materials 
Showdomycin was obtained from Charles Druce 
Ltd., London, W. 1; NEM* from Hopkin and Williams, 
Chadwell Heath, Essex. E. coli MRE 600 was obtained 
from the Microbiological Research Establishment, Por- 
ton Down, Wiltshire. 
2.2. Enzyme isolation 
The polymerase was isolated from E. coli MRE 600 
by modification of the general procedure of Furth, 
Hurwitz and Anders [3] . All buffers contained 0.5 mM 
EDTA and 1 mM /3-mercaptoethanol. After breaking 
100 g of cells with glass beads and centrifuging at 
78,OOOg, the supernatant was titrated with 0.5% 
protamine sulphate solution to give 90% precipitation 
of the enzyme. Inactive protein was extracted from 
the protamine precipitate with 0.03 M ammonium 
sulphate in 0.01 M trisHC1, pH 7.5, followed by 
elution of the enzyme with 0.15 M ammonium sul- 
phate in 0.01 M imidazole-HCl, pH 6.5. The protamine 
eluate was then fractionated with saturated ammonium 
sulphate, and the 37%-52% precipitate retained. 
Finally, after separation of this fraction on DEAE-cel- 
lulose with a linear gradient of 0.1 M-0.5 M KC1 in 
0.01 M tris-HCl, pH 7.5, the peak containing enzyme 
was concentrated by ammonium sulphate precipitation 
and run on Sephadex G-100 in 1.3 M ammonium sul- 
* Abbreviations 
NEM, N-ethyhnaleimide 
NTP, nucleoside triphosphate 
UMP, uridine monophosphate 
DTNB, 5,5’-dithiobis(2-nitrobenzoic acid) 
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phate in 0.0 1 M tris-HCl, pH 7.5, to remove a lower 
molecular weight inhibitor. Enzyme was stored in a 
buffer containing 0.2 M ammonium sulphate, 40% 
glycerol, 0.05 M tris-HCl and 0.5 mM each EDTA and 
dithiothreitol, pH 7.5. 
As isolated the enzyme had a specific activity of 
approximately 2000 units/mg protein. (1 unit incorpo- 
rates 1 nmole of 14C-AMP per hour into an acid-in- 
soluble form). The 280/260 ratio was 1.5- 1.6. The 
enzyme was completely DNAdependent. 
2.3. Enzyme assay 
The enzyme assay contained the following in a 
volume of 0.25 ml: 50 mM tris-HCl, pH 7.5; 8 mM 
MgCIZ ; 2 mM MnCl*; 0.4 mM each CTP, GTP, UTP and 
8-14C-ATP (106 cpm/mole); 40 l.(g calf thymus DNA; 
and 2-10 pg enzyme protein. The omission of mer- 
captoethanol had little effect on the amount of 14C- 
AMP incorporation. After incubation at 37’C for 10 
min, the reaction was stopped with 5 pmoles EDTA 
followed by 3 ml of ice-cold 0.5 N perchloric acid 
containing 0.125 M sodium pyrophosphate, and the 
radioactivity collected on 0.45 pm Millipore filters 
which were then washed successively with 0.5 N per- 
chloric acid, ethanol and toluene, dried, and counted 
by liquid scintillation. 
2.4. Inhibition experiments 
The enzyme (about 2 mg) in storage buffer was di- 
luted 2- to 5-fold with dialysis buffer (0.01 M tris-HCl, 
15% glycerol, 0.5 mM EDTA) and precipitated by ad- 
dition of 1.2 volumes of saturated ammonium sulphate. 
It was then dissolved in dialysis buffer and dialysed 
against 100 volumes of the same buffer for 18 to 22 hr. 
About 30 to 50% of the activity was lost in this proce- 
dure; bubbling solutions with oxygen-free nitrogen did 
not prevent this loss. For inhibition, 0.02-0.05 ml por- 
tions of dialysed enzyme were mixed with 2 volumes 
of dialysis buffer and 1 volume of inhibitor dissolved 
in the same buffer. After incubation at 37°C aliquots 
were removed at intervals and assayed in the standard 
system. In each experiment, a control tube, containing 
enzyme but no inhibitor was similarly incubated and 
samples of it assayed. 
Protein concentration was determined from the ex- 
tinction at 280 nm using an E{:m of 6.5 as described 
by Richardson [4] . 
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3. Results 
Fig. 2 shows the effect of preincubating RNA 
polymerase in the presence of various concentrations 
of showdomycin or NEM. In the experiment shown, 
after 30 min preincubation, 50% inactivation was ob- 
tained with showdomycin at a concentration of 2.5 
mM whereas only 0.3 mM NEM was required to pro- 
duce the same result. It was also found that when 
showdomycin was added directly to the assay mixture 
in a final concentration of 1.6 mM it had no inhibitory 
effect. 
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Fig. 2. Effect of preincubating RNA polymerase in the pre- 
sence of various concentrations of showdomycin and NEM. 
Incubation mixtures contained 36 units of enzyme, showdo- 
mycin or NEM in varying concentrations, and dialysis buffer 
in a total volume of 80 ~1. After 30 minutes incubation at 
37’C, 25 ~1 aliquots were removed for assay in the standard 
assay mixture. The control was incubated in the same way, 
but contained only enzyme and buffer. 100% activity re 
maining at 30 minutes, based on this control, was equal to an 
incorporation of 1.27 nmoles of L‘k-AMP in the 10 minute 
assay. 
u showdomycin - NEM. 
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Fig. 3. Inactivation of RNA polymerase by showdomycin as a 
function of preincubation time. 
Incubation mixtures contained either 156 or 312 units of en- 
zyme, showdomycin at a final concentration of 2 mM, and 
dialysis buffer, in a total volume of 0.4 ml. Incubations were 
carried out at 37OC. At various times after the addition of en- 
zyme, 20 ~1 aliquots were removed for assay in the standard 
assay mixture. The control contained only enzyme and buffer. 
1 Initial activity was 1.75 mnoles 14C-AMP incorporated for 312 
0 20 40 80 units of enzyme, 0.895 nmoles for 156 units of enzyme. 
MINUTES W--O 156 units enzyme - 3 12 units enzyme e--c control. 
Table 1 
Protection of RNA polymerase by components of the standard assay mixture against inactivation by showdomycin and NEM. 
Addition 
None 
Amount of component added 
% Activity remaining after 30 min 
Showdomycin NEM 
100 (2.35 nmoles) 100 (3.28 mnoles) 
Inhibitor 51 67 
Inhibitor + DNA 7 ecg 57 71 
14 fig 67 71 
28 ccg 108 81 
70 /Jg 110 100 
Inhibitor + metals 2 mM Mg2+ + 0.5 mM Mn2+ 69 86 
4 mM Mg2+ + 1 mM Mn2+ 69 84 
8 mM Mg2+ + 2 mM Mn2+ 75 83 
20 mM Mg2+ + 5 mM Mn2+ 82 103 
Inhibitor + NTP’s 0.25 mM each 52 71 
0.50 mM each 59 69 
0.75 mM each 59 68 
1 .OO mM each 59 67 
Incubation mixtures contained either showdomycin, 2 mM, or NEM, 0.2 mM, except in the control; enzyme, 56 units in the show- 
domycin experiment, 79 units in the NEM experiment; and the components listed, in a final volume of 0.2 ml. The mixtures were 
incubated 5 min at 37’C prior to the addition of inhibitor. After a further 30 mm at 37OC, 50 ~1 aliquots were removed for assay. The 
assay mixtures were adjusted so that the final concentration of each component was brought to its normal level by the addi- 
tion of the aliquot. 
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Fig. 3 shows that when the enzyme is preincubated UMP phosphorylation at concentrations of 1.5 to 2.5 
with showdomycin at a concentration of 2 mM, there mM. 
is an exponential loss of activity with time, the rate Fig. 2 makes it clear that NEM is a more effective 
varying with enzyme concentration. inhibitor of RNA polymerase than is showdomycin. 
Since loss of activity is dependent on preincubation This could be due either to differences in the reacti- 
of the polymerase with showdomycin in the absence vity of the two maleimides or to steric hindrance by 
of substrate, the antibiotic is acting directly on the the ribose group in showdomycin. Although both 
enzyme. Further experiments were therefore under- showdomycin and NEM are unable to attack the 
taken to determine which of the components of the enzyme-DNA complex, it is interesting that the metals, 
assay mixture were capable of protecting against the which are not essential for binding the enzyme to 
inactivation of the enzyme by showdomycin. The re- DNA [7] , do afford some protection against inacti- 
sults are shown in table 1. For comparison a similar vation. However, addition of the NTP’s to the metals 
set of experiments was conducted using NEM. eliminates the protection which they offer, probably 
NTP’s alone afforded little protection against inacti- by chelation. 
vation by either showdomycin or NEM. On the other Since maleimides will react with both amino and 
hand, increasing concentrations of metals alone pro- sulphydryl groups [8], the nature of the alkylation 
vided some protection against showdomycin, although remains to be studied. In other experiments we have 
against NEM protection was complete. However, in found that DTNB, as well as p-chloromercuribenzoate, 
three separate xperiments a mixture of NTP’s and iodoacetamide and bromopyruvate will also inactivate 
metals in the proportions used in the assay gave no RNA polymerase of E. coli. 
better protection against showdomycin than NTP’s 
alone. Only DNA provided complete protection against 
both showdomycin and NEM. The antibiotic therefore Acknowledgements 
attacks the free enzyme but not the enzyme-DNA com- 
plex. The only other antibiotic knwon to inhibit RNA We wish to thank Dr. A.P.Mathias and Professor 
polymerase by direct attack on the enzyme is rifam- B.R.Rabin for helpful advice. We also thank the Cen- 
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same period of time, loss of activity was less than 10%. 
It was ascertained that showdomycin and NEM so- 
lutions in dialysis buffer were stable during the time in 
which inhibition experiments were performed. After 
incubation for 90 min at 37°C showdomycin and NEM 
had lost none of their effectiveness in activating RNA 
polymerase. 
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